Colorectal Cancer Trial, Recruiting NCT03466424 Sponsor: Fujian Medical University Union Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT03466424
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with rectal cancer (confirmed by biopsy) that is at a certain stage (T3-4 and/or has spread to nearby lymph nodes), has not been treated before, can be removed by surgery, and is located within 12 cm of the anal opening
  • Men or women who are not pregnant
  • People aged between 18 and 70 years old
  • People whose blood cell counts and haemoglobin levels are within acceptable ranges, showing the bone marrow is working well enough
  • People whose kidneys are functioning well enough, based on a blood test result within acceptable limits
  • People whose liver is functioning well enough, based on blood test results within acceptable limits
  • People who are well enough to carry out most daily activities, as measured by a standard performance scale (KPS score of 70 or above)
  • People who have given written consent to participate before joining the trial

Who may not be able to join:

  • People whose cancer has come back or has spread to other parts of the body
  • People who are already receiving other cancer treatments or therapies
  • People who are unlikely to be able to complete the full trial due to low likelihood of following the required steps
  • People who have another serious or life-threatening illness that is not under control
  • People who have significant problems with the heart, brain, lungs, or other major organs

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Benhua Xu, Fujian Medical University Union Hospital

Phone: 86+13696884375

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fujian Medical University Union Hospital
Registry
ClinicalTrials.gov
Start date
1 August 2022
Est. completion
1 June 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Pathological complete response(pCR) rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov